Loading...

BBNX BETA BIONICS INC Management Changes 8-K Filing

BT B

BBNX

BETA BIONICS INC

(BBNX)

2025 8-K

Financial Results

FDA Warning Letter

Preliminary Q4 Results

Financial Results Released

Financial Statements

New Product Launches

Financial Statements

Director Appointment

Financial Results

External Links:

On March 26, 2025, Beta Bionics appointed Gerard Michel as a Class III director with a $50,000 annual cash retainer and 12,547 restricted stock units that vest after one year, subject to his continuous service.

AI Assistant

BETA BIONICS INC

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.